EIKEN CHEMICAL CO.,LTD. Logo

EIKEN CHEMICAL CO.,LTD.

Manufacturer of clinical diagnostics, medical equipment, and gene amplification technology.

4549 | T

Overview

Corporate Details

ISIN(s):
JP3160700005
LEI:
Country:
Japan
Address:
台東区台東四丁目19番9号

Description

EIKEN CHEMICAL CO., LTD. is a manufacturer specializing in clinical diagnostics and medical equipment. Established in 1939, the company has a history of innovation, including being the first in Japan to commercialize powdered culture media for microbiological investigations. Its core business encompasses the development, manufacturing, and sale of a wide range of diagnostic reagents and equipment. Key product areas include Fecal Immunochemical Test (FIT) systems for colorectal cancer screening, immunological and serological reagents, and microbiological diagnostics. EIKEN is also the developer of the proprietary Loop-mediated Isothermal Amplification (LAMP) method, a rapid gene amplification technology widely used in molecular diagnostics for infectious diseases and other applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 02:00
確認書
Japanese 9.3 KB
2025-11-11 02:00
半期報告書-第88期(2025/04/01-2026/03/31)
Japanese 237.3 KB
2025-09-18 07:32
発行登録書(株券、社債券等)
Japanese 32.0 KB
2025-08-08 09:09
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.0 KB
2025-07-10 08:23
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.4 KB
2025-06-25 03:09
訂正発行登録書
Japanese 10.2 KB
2025-06-25 03:05
臨時報告書
Japanese 32.3 KB
2025-06-25 03:00
内部統制報告書-第87期(2024/04/01-2025/03/31)
Japanese 27.1 KB
2025-06-25 03:00
有価証券報告書-第87期(2024/04/01-2025/03/31)
Japanese 2.0 MB
2025-06-25 03:00
確認書
Japanese 9.1 KB
2025-06-24 09:54
訂正発行登録書
Japanese 10.2 KB
2025-06-24 09:51
臨時報告書
Japanese 39.7 KB
2025-06-10 09:22
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.0 KB
2025-05-12 03:18
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 28.2 KB
2025-04-10 05:00
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.2 KB

Automate Your Workflow. Get a real-time feed of all EIKEN CHEMICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EIKEN CHEMICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EIKEN CHEMICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.